加味散结方治疗甲状腺结节的疗效观察
|
摘要
目的:探究加味散结方治疗甲状腺结节的的临床效果,以供临床参考。方法:收集2015年1月-2017年9月在我院入院治疗的甲状腺结节患者66例,分为对照组33例和治疗组33例,对照组采用中成药夏枯草胶囊治疗,治疗组则采用加味散结方治疗。治疗6个月后,比较两组治疗方案的治疗效果,并寻找各自的优越性所在。结果:治疗前两组各指标差异不显著,P> 0.05;治疗后,治疗组结节直径为(0.56±0.05)cm、中医证候积分为(5.95±2.03)分,均低于对照组;治疗组血清总维生素D水平为(43.6±7.02),显著高于对照组的(34.53±5.13);差异具有统计学意义,P <0.05;治疗组治疗后优良率(93.9%)高于对照组,差异具有统计学意义,P <0.05。结论:对于甲状腺结节患者予以加味散结方治疗,其效果比较明显,优于中成药治疗效果,值得临床推广。
Objective: To explore the clinical efficacy of the Sanjie prescription( 散结方) on thyroid nodule. Methods: 66 cases were divided into the control group and treatment group, 33 cases in each. The control group was given the Xiakucao capsule( 夏枯草胶囊).The treatment group was given the Sanjie prescription. After 6 months, clinical efficacy between two groups was compared. Results: The difference between two groups was not significant, P>0.05. After treatment, nodule diameter and TCM syndrome scores in the treatment group were lower than the control group. Serum total vitamin D level in the treatment group was significantly higher than the control group,with significant differences, P<0.05. The efficiency in the treatment group was significantly better than the control group, with a significant difference, P<0.05. Conclusion: The Sanjie prescription shows an obvious effect, and is worthy of popularization.
Objective: To explore the clinical efficacy of the Sanjie prescription( 散结方) on thyroid nodule. Methods: 66 cases were divided into the control group and treatment group, 33 cases in each. The control group was given the Xiakucao capsule( 夏枯草胶囊).The treatment group was given the Sanjie prescription. After 6 months, clinical efficacy between two groups was compared. Results: The difference between two groups was not significant, P>0.05. After treatment, nodule diameter and TCM syndrome scores in the treatment group were lower than the control group. Serum total vitamin D level in the treatment group was significantly higher than the control group,with significant differences, P<0.05. The efficiency in the treatment group was significantly better than the control group, with a significant difference, P<0.05. Conclusion: The Sanjie prescription shows an obvious effect, and is worthy of popularization.
引文
[1]姚玥含.中药化痰祛瘀散结方对甲状腺结节的治疗效果研究[J].中国医药指南,2017,15(15):178-179.
[2]郑泽霖,盖宝东,季德刚.关于甲状腺结节的讨论[J].中国普通外科杂志,2003,12(10):721-722.
[3]强雨叶,王旭.中药治疗甲状腺结节研究进展[J].实用中医药杂志,2016,32(7):747-748,749.
[4]陈大勇,赵晓伟,张勇.中药复方治疗甲状腺结节临床疗效[J].中国实用医药,2016,11(36):127-128.
[5]刘芳,余江毅.抗甲状腺结节中药的研究概况[J].江苏中医药,2014,46(3):80-81.
[6]贾茉莉,周军.瘿病的中医治疗[J].中外健康文摘,2011,8(27):413-414.
[7]牟兴宇,付巍.甲状腺结节临床诊断进展[J].标记免疫分析与临床,2016,23(5):575-578.
[8]张彩芬,贾思跃,王丽娟,等.中药治疗甲状腺结节52例临床观察[J].医学研究与教育,2015,32(4):10-12.
[2]郑泽霖,盖宝东,季德刚.关于甲状腺结节的讨论[J].中国普通外科杂志,2003,12(10):721-722.
[3]强雨叶,王旭.中药治疗甲状腺结节研究进展[J].实用中医药杂志,2016,32(7):747-748,749.
[4]陈大勇,赵晓伟,张勇.中药复方治疗甲状腺结节临床疗效[J].中国实用医药,2016,11(36):127-128.
[5]刘芳,余江毅.抗甲状腺结节中药的研究概况[J].江苏中医药,2014,46(3):80-81.
[6]贾茉莉,周军.瘿病的中医治疗[J].中外健康文摘,2011,8(27):413-414.
[7]牟兴宇,付巍.甲状腺结节临床诊断进展[J].标记免疫分析与临床,2016,23(5):575-578.
[8]张彩芬,贾思跃,王丽娟,等.中药治疗甲状腺结节52例临床观察[J].医学研究与教育,2015,32(4):10-12.